US Internet study "good news for enforcement"

9 January 2006

A US study of web sites selling controlled prescription medications has found that a number of sites which are illicit have been in operation for more than a year and are being operated from within the USA.

This discovery suggests that law enforcement operations against the sites are possible, says the report, adding that "a concerted, programmatic effort" to take them down could have a significant impact on illicit product availability.

The investigation was conducted by New Jersey-based firm IntegriChain on behalf of the US House Energy and Commerce Committee's subcommittee on oversight and investigations, which conducted hearings in December 2005 on ways in which efforts to combat Internet sales of controlled substances might be strengthened.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight